[1]
“Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: Proactive Versus Reactive Strategies”, TMTJ, vol. 2, no. 1, pp. 28–36, Apr. 2023, doi: 10.5281/zenodo.22649043.